Discovered key mechanisms to improve intestinal regeneration and alleviate the side effects of radiotherapy – EurekAlert
stemadminStem Cell ResearchNo comments

image:Karla Santos-de-Frutos and Nabil Djouder in the lab. view more Credit: Antonio Tabernero. CNIO The intestine is very susceptible and is affected by the harsh conditions caused by DNA-altering agents, such as radiation and chemotherapy, during cancer treatment. For example, many patients with tumours in the gastrointestinal cavity receive radiotherapy, a treatment that often also damages the healthy intestine and affects its regenerative capacity. It is therefore very important to understand how intestinal epithelial regeneration occurs

Read more
What may have given modern humans an edge over Neanderthals, according to new research – kuna noticias y kuna radio
stemadminStem Cell ResearchNo comments

By Katie Hunt, CNN From studying fossilized skulls, scientists know that the size of a Neanderthals brain was the same as, if not slightly bigger than, that of a modern human. However, researchers have known little about Neanderthal brain development because soft tissue doesnt preserve well in the fossil record. Now, an intriguing study released September 8 has revealed a potential difference that may have given modern humans, or Homo sapiens, a cognitive advantage over the Neanderthals, the Stone Age hominins who lived in Europe and parts of Asia before going extinct about 40,000 years ago. Scientists at the Max Planck Institute of Molecular Cell Biology and Genetics in Dresden, Germany, said they have identified a genetic mutation that triggered the faster creation of neurons in the Homo sapiens brain.

Read more
Cell Culture Media Market worth $10.3 billion by 2026 – Exclusive Report by MarketsandMarkets – GlobeNewswire
stemadminStem Cell ResearchNo comments

Chicago, Sept. 13, 2022 (GLOBE NEWSWIRE) -- According to the new market research report "Cell Culture Media Market by Type(Serum-free (CHO, BHK, Vero Cell), Stem Cell, Chemically Defined, Classical, Specialty), Application(Biopharmaceutical (mAbs, Vaccine), Diagnostics, Tissue Engineering), End User(Pharma, Biotech) - Global Forecast to 2026", is projected to USD 10.3 billion by 2026 from USD 4.9 billion in 2021, at a CAGR of 16.0 % between 2021 and 2026. Browse in-depth TOC on "Cell Culture Media Market"314 - Tables41 - Figures303 - Pages Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=97468536 The growth of this market is majorly driven by the rising R&D spending in pharmaceutical companies, emerging cell culture technologies for cell-based vaccines, increasing demand for monoclonal antibodies, growth in stem cell research, the launch of new cell culture media by market players, and the growing focus on personalized medicine. On the other hand, expensive cell biology research products and ethical concerns regarding cell biology research are expected to hinder the growth of this market. Based on type, the cell culture media market is segmented intoserum-free media, classical media & salts, stem cell culture media, specialty media, chemically defined media, and other cell culture media

Read more
Stem Cell Ucb Market Opportunities, Future Plans, Competitive Landscape, and Growth by Forecast 2030 – Taiwan News
stemadminStem Cell ResearchNo comments

Report Ocean recently added a research report on the Stem Cell Ucb market. The report includes an extensive analysis of the markets characteristics, COVID-19 impact, size and growth, segmentation, regional and country breakdowns, competitive environment, market shares, trends, and strategies. In addition, it traces the development of the market over time and projects regional market growth.

Read more
NIH researchers develop gene therapy for rare ciliopathy – National Institutes of Health (.gov)
stemadminStem Cell ResearchNo comments

News Release Thursday, September 8, 2022 Gene augmentation rescues cilia defects in light-sensing cells derived from patients with blinding disease. Researchers from the National Eye Institute (NEI) have developed a gene therapy that rescues cilia defects in retinal cells affected by a type of Leber congenital amaurosis (LCA), a disease that causes blindness in early childhood. Using patient-derived retina organoids (also known as retinas-in-a-dish), the researchers discovered that a type of LCA caused by mutations in the NPHP5 (also called IQCB1) gene leads to severe defects in the primary cilium, a structure found in nearly all cells of the body. The findings not only shed light on the function of NPHP5 protein in the primary cilium, but also led to a potential treatment for this blinding condition. NEI is part of the National Institutes of Health

Read more
Aflac and Be The Match partner to help diversify the National Blood Stem Cell Donor Registry and improve health equity – PR Newswire
stemadminStem Cell ResearchNo comments

NBA player Marcus Smart joins partnership to advocate for patients battling blood cancers and blood diseases COLUMBUS, Ga. and MINNEAPOLIS, Sept. 8, 2022 /PRNewswire/ -- Highlighting its 27-year commitment to children and families facing childhood cancer and sickle cell disease (SCD), Aflac, the number one provider of supplemental health insurance in the U.S.1 and Be The Match, operated by the National Marrow Donor Program, which has helped facilitate more than 111,000 blood stem cell transplants worldwide, today announced a partnership to continue diversifying the national blood stem cell donor registry. The agreement is part of Aflac's overall campaign commemorating National Childhood Cancer Awareness Month and National Sickle Cell Awareness Month, both of which occur in September. Since 1995, Aflac has contributed more than $160 million to the Aflac Cancer and Blood Disorders Center at Children's Healthcare of Atlanta, the largest sickle cell care provider in the United States

Read more
New stem cell therapy provides long-term brain protection against ALS – Study Finds
stemadminStem Cell ResearchNo comments

LOS ANGELES Cedars-Sinai researchers say a new stem cell therapy procedure allows them to protect patients with ALS, or Lou Gehrigs disease, and helps block muscle deterioration which normally occurs as a result of the fatal neurological disorder. The Cedars-Sinai team successfully engineered and embedded protective proteins through the blood-brain barrier of patients with amyotrophic lateral sclerosis (ALS). The procedure increases hope that similar one-time treatments will greatly slow the diseases degenerative effects, including limb paralysis and the loss of ones ability to move, speak, or breathe. Researchers did not encounter any negative side-effects, while patients avoided leg paralysis following the transplant and replication of protein-producing stem cells from patients central nervous systems. This breakthrough investigational therapy promotes the survival of motor neurons which typically degenerate in the spinal cord of patients with ALS

Read more

Theme: Illdy.